Factors Influencing the Duration of Termination of Pregnancy for Fetal Anomaly with Mifepristone in Combination with Misoprostol

被引:2
|
作者
Reischer, Theresa [1 ]
Limbach, Iris [1 ]
Catic, Anja [1 ]
Niedermaier, Katrin [1 ]
Falcone, Veronica [1 ]
Yerlikaya-Schatten, Guelen [1 ]
机构
[1] Med Univ Vienna, Dept Obstet & Gynaecol, Div Obstet & Feto Maternal Med, A-1090 Vienna, Austria
关键词
termination of pregnancy; feticide; fetal malformation; genetic abnormalities; induction of labor; mifepristone; misoprostol; fetal expulsion; 2ND-TRIMESTER TERMINATION; GESTATIONAL-AGE; LABOR; INDUCTION; INTERVAL; WOMEN;
D O I
10.3390/jcm12030869
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study's aim was to determine relevant factors that influence the time interval between first induction and fetal expulsion in late termination of pregnancy (TOP) and TOP after previous feticide for severe fetal malformation with a mifepristone-misoprostol regime. This retrospective study included 913 TOPs from a single tertiary care referral center. In 197 out of 913 TOPs, a previous feticide had been performed due to advanced gestational age (after 22 + 0 weeks of gestation). Induction was accomplished using 600 mg mifepristone followed by 400 mu g misoprostol. The interval between first induction with misoprostol and fetal expulsion was examined. Univariate and multivariate logistic regression analysis were used to predict an induction interval of 12 h or less. The median gestational age at induction of labor was 18.9 weeks of pregnancy. In 487 (53.3%) cases women delivered within 12 h; in 344 (37.7%) cases the induction interval was between 12 h and 36 h. In 82 (9%) cases induction took longer than 36 h. Factors that were significantly associated with a delivery duration of <12 h were a lower gestational age at induction (OR 0.87; 95% CI 0.84-0.89; p < 0.001) and a history of at least one previous vaginal delivery (OR 1.57; 95% CI 1.20-2.05; p < 0.001). Factors that had no impact included previous cesarean section, performing feticide before induction and maternal age. Maternal BMI showed a non-significant trend.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Factors influencing outcomes of pregnancy termination with intravaginal misoprostol for fetal anomaly
    Dickinson, Jan
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (06) : S99 - S99
  • [2] Factors influencing the duration of pregnancy termination with vaginal misoprostol for fetal abnormality
    Dickinson, Jan E.
    Doherty, Dorota A.
    [J]. PRENATAL DIAGNOSIS, 2009, 29 (05) : 520 - 524
  • [3] The combination of mifepristone and misoprostol for the termination of pregnancy
    Faundes, Anibal
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2011, 115 (01) : 1 - 4
  • [4] Second trimester termination of pregnancy for fetal anomaly or death: comparing mifepristone/misoprostol to gemeprost
    le Roux, PA
    Pahal, GS
    Hoffman, L
    Nooh, R
    El-Refaey, H
    Rodeck, CH
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 95 (01) : 52 - 54
  • [5] Short versus standard mifepristone and misoprostol regimen for second and third trimester termination of pregnancy for fetal anomaly
    Sharp, A.
    Navaratnam, K.
    Abreu, P.
    Alfirevic, Z.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 : 58 - 58
  • [6] Comment on the combination of mifepristone and misoprostol for the termination of second-trimester pregnancy
    Chen, Yen-Po
    Wang, Peng-Hui
    Tsui, Kuan-Hao
    [J]. TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2015, 54 (04): : 469 - 470
  • [7] Short versus Standard Mifepristone and Misoprostol Regimen for Second- and Third-Trimester Termination of Pregnancy for Fetal Anomaly
    Sharp, Andrew
    Navaratnam, Kate
    Abreu, Patricia
    Alfirevic, Zarko
    [J]. FETAL DIAGNOSIS AND THERAPY, 2016, 39 (02) : 140 - 146
  • [8] Early pregnancy termination with mifepristone and misoprostol in Norway
    Bjorge, L
    Johnsen, SL
    Midboe, G
    Augestad, G
    Okland, I
    Helland, H
    Stray-Pedersen, S
    Iversen, OE
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2001, 80 (11) : 1056 - 1061
  • [9] Misoprostol vs mifepristone and misoprostol in second trimester termination of pregnancy
    Tripti N.
    Namrata S.
    [J]. The Journal of Obstetrics and Gynecology of India, 2011, 61 (6) : 659 - 662